摘要

This study was supported by National Science Council (NSC 102-2314-B-038-048) to PHF, Ministry of Science and Technology (MOST 103-2314-B-038 -056 and 104-2314-B-038-070) to PHF, and Taipei Medical University (TMU103- AE1-B31, TMU103-AE2-I01-3, 103TMU-SHH-01-2, 105TMU-SHH-02-2) to PHF.
原文英語
頁數1
期刊Oncotarget
9
發行號59
DOIs
出版狀態已發佈 - 一月 26 2018

指紋

Technology
Adenocarcinoma of lung
Myeloid-Derived Suppressor Cells

ASJC Scopus subject areas

  • Oncology

引用此文

@article{39e4bed62fa24ba59979ab3627b63035,
title = "Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146",
abstract = "This study was supported by National Science Council (NSC 102-2314-B-038-048) to PHF, Ministry of Science and Technology (MOST 103-2314-B-038 -056 and 104-2314-B-038-070) to PHF, and Taipei Medical University (TMU103- AE1-B31, TMU103-AE2-I01-3, 103TMU-SHH-01-2, 105TMU-SHH-02-2) to PHF.",
author = "Feng, {Po Hao} and Yu, {Chih Teng} and Chen, {Kuan Yuan} and Luo, {Ching Shan} and Wu, {Shen Ming} and Liu, {Chien Ying} and Kuo, {Lu Wei} and Chan, {Yao Fei} and Chen, {Tzu Tao} and Chang, {Chih Cheng} and Lee, {Chun Nin} and Chuang, {Hsiao Chi} and Lin, {Chiou Feng} and Han, {Chia Li} and Lee, {Wei Hwa} and Lee, {Kang Yun}",
year = "2018",
month = "1",
day = "26",
doi = "10.18632/oncotarget.25943",
language = "English",
volume = "9",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "59",

}

TY - JOUR

T1 - Correction

T2 - S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146

AU - Feng, Po Hao

AU - Yu, Chih Teng

AU - Chen, Kuan Yuan

AU - Luo, Ching Shan

AU - Wu, Shen Ming

AU - Liu, Chien Ying

AU - Kuo, Lu Wei

AU - Chan, Yao Fei

AU - Chen, Tzu Tao

AU - Chang, Chih Cheng

AU - Lee, Chun Nin

AU - Chuang, Hsiao Chi

AU - Lin, Chiou Feng

AU - Han, Chia Li

AU - Lee, Wei Hwa

AU - Lee, Kang Yun

PY - 2018/1/26

Y1 - 2018/1/26

N2 - This study was supported by National Science Council (NSC 102-2314-B-038-048) to PHF, Ministry of Science and Technology (MOST 103-2314-B-038 -056 and 104-2314-B-038-070) to PHF, and Taipei Medical University (TMU103- AE1-B31, TMU103-AE2-I01-3, 103TMU-SHH-01-2, 105TMU-SHH-02-2) to PHF.

AB - This study was supported by National Science Council (NSC 102-2314-B-038-048) to PHF, Ministry of Science and Technology (MOST 103-2314-B-038 -056 and 104-2314-B-038-070) to PHF, and Taipei Medical University (TMU103- AE1-B31, TMU103-AE2-I01-3, 103TMU-SHH-01-2, 105TMU-SHH-02-2) to PHF.

UR - http://www.scopus.com/inward/record.url?scp=85050959141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050959141&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.25943

DO - 10.18632/oncotarget.25943

M3 - Comment/debate

AN - SCOPUS:85050959141

VL - 9

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 59

ER -